• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

GlaxoSmithKline (GSK) - Articles and news items

Emma Walmsley

First female CEO to lead GSK as Emma Walmsley succeeds Andrew Witty

Industry news / 20 September 2016 / Niamh Louise Marriott, Digital Content Producer

She will succeed Andrew Witty as GSK CEO, when he retires on 31st March 2017. She will be the first female CEO of a major global pharmaceuticals company…


Janssen submits EU application for rheumatoid arthritis drug

Industry news / 16 September 2016 / Niamh Louise Marriott, Digital Content Producer

Sirukumab is a human monoclonal IgG1 kappa antibody that targets the cytokine IL-6, a protein believed to play a role in autoimmune rheumatoid arthritis…

global hiv treatment

Global dual-drug trial aims to advance HIV treatment

Industry news / 16 August 2016 / ViiV Healthcare

ViiV Healthcare is undertaking two identical studies as part of a global phase III programme comparing a two-drug regimen of dolutegravir plus lamivudine, with a three-drug regimen of dolutegravir (Tivicay), plus the fixed-dose tablet tenofovir/emtricitabine (Truvada), to support regulatory filings as a treatment for HIV, for adults who have had no prior antiretroviral therapy…

GSK UoL collaborate cancer treatment

GSK teams up with University of Leicester in search of cancer treatments

Industry news / 21 July 2016 / Niamh Louise Marriott, Digital Content Producer

global pharmaceutical company GlaxoSmithKline has been established to discover and develop novel medicines to treat aggressive forms of blood cancer…


MenABCWY set to revolutionise the meningococcal vaccine market

Industry news / 29 June 2016 / Victoria White, Digital Content Producer

GlobalData says MenABCWY has the potential to significantly change the approach used to prevent meningococcal disease…


Greater response with GSK’s Benlysta vs placebo in SLE study

Industry news / 8 June 2016 / Victoria White, Digital Content Producer

Patients with SLE experienced a significantly greater response to treatment with Benlysta administered via subcutaneous injection compared to placebo…


Sirukumab meets both co-primary endpoints in rheumatoid arthritis study

Industry news / 8 June 2016 / Victoria White, Digital Content Producer

The SIRROUND-D study met both co-primary endpoints in evaluating treatment with sirukumab in adult patients with active rheumatoid arthritis…


From HIV to oncology: widening access through flexible IP

Blog, Z Homepage promo / 28 April 2016 / Jon Pender, VP Government Affairs, GSK

Jon Pender, GSK, discusses how a flexible and thoughtful approach to IP can help get medicines to the poorest and hardest-to-reach patients around the world…


GSK adopts groundbreaking IP approach to expand access to its medicines

Industry news / 31 March 2016 / Victoria White

Sir Andrew Witty has set out a series of steps designed to help bring innovative GSK medicines to more people living in the world’s poorest countries…


Integrated, predictive and collaborative workflows in biologics discovery

Webinars / 23 March 2016 / Dassault Systèmes BIOVIA & GlaxoSmithKline

As well as delving into secure data sharing, the speakers from BIOVIA and GSK will discuss implementing the BIOVIA Biological Registration solution. The speakers will highlight the importance of effective IP protection and improved decision-making through an integrated and collaborative platform…

Industrial Pharmaceutical Sieves for Powders at GSK

Industrial Pharmaceutical sieves for powders at GSK

Supplier news / 26 February 2016 / Russell Finex Ltd

GlaxoSmithKline is improving process efficiency in the production of pharmaceutical powders at its “centre of excellence” plant in Dartford, Kent, by investing in nine new industrial pharmaceutical sieves fitted with the Vibrasonic® Deblinding System from Russell Finex…


Phase III study of sirukumab in giant cell arteritis starts

Industry news / 27 November 2015 / Victoria White

Sirukumab is an investigational human anti-IL-6 monoclonal antibody that selectively binds with high affinity to the IL-6 cytokine…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +